Addition of an estimate value of glomerular filtration rate (GFR) per MDRD (LEVEY) equation is being added and reported on all routine chemistry panels in the experimental group. The control group is only having serum creatinine, the current standard of care, reported on routine chemistry panels.

Condition
Chronic Kidney Disease

Further Study Details: 

Expected Total Enrollment:  1500

All patients already referred to or being followed by nephrologists were excluded. Inclusion criteria were all patients in the Internal Medicine clinic at NMCSD who were sent to the lab to obtain routine chemistry panels for follow up by their primary care providers. The primary outcome is increased referral to nephrology in accordance with NKF K/DOQI guidelines if GFR values are reported on routine chemistry panels. Key secondary outcomes are Primary Care Provider knowledge of NKF K/DOQI guidelines, specifically when patients with chronic kidney disease need to be referred to a nephrologist for further evaluation.

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

• All patients in Internal Medicine Clinic at NMCSD who were sent to the lab to obtain follow up by their primary care providers.

Exclusion Criteria:

• All patients referred to or being followed by nephrologists.

Please refer to this study by ClinicalTrials.gov identifier  NCT00134797

Heather J Miller, M.D.       HJMiller1@nmcsd.med.navy.mil

California
      Naval Medical Center San Diego, San Diego,  California,  92134,  United States; Recruiting

Study chairs or principal investigators

Heather J Miller, M.D.,  Principal Investigator,  Naval Medical Center San Diego   

Study ID Numbers:  CIP #S-04-058
Last Updated:  August 24, 2005
Record first received:  August 24, 2005
ClinicalTrials.gov Identifier:  NCT00134797
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-08-30